Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 44,574 shares at $41.00 ($1.8M) on 2020-10-09, disclosed to the SEC on 2020-10-09.
Open-market sale of $1.8M ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.00 | 5,065 | $208K | 11.4% |
| 2 | $41.00 | 39,509 | $1.6M | 88.6% |
| Total | $41.00 avg | 44,574 | $1.8M | 100% |
| Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |
| ALLO | SELL | 2020-10-13 | $1.5M | — | Filing → |